Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Die Rolle von Kollagen IV und seiner Matrikine in der pulmonalen Fibrose.
Projektleitung: Berg Johannes Lorenz
Laufzeit: 01.12.2025 - 31.08.2026
Geldgeber: Kulturamt der Stadt Graz

Interleukin-15 und regulatorische CD8 T-Zellen
Projektleitung: Mooslechner Agnes Anna
Laufzeit: 01.04.2026 - 31.03.2027
Geldgeber: Österreichische Akademie der Wissenschaften, ÖAW

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):

13.02.2026:

Rappl, T; Voljc, T; Ruschitzka, R; Luze, H; Kamolz, LP; Feigl, G; Nischwitz, SP Surface-Based Localization of the Spinal Accessory Nerve in the Posterior Triangle: A High-Volume Cadaveric Study Defining a Clinically Applicable Danger Zone.
Plast Reconstr Surg. 2026; Doi: 10.1097/PRS.0000000000012930
PubMed FullText FullText_MUG

 

12.02.2026:

Eichlseder, M; Schweikert, R; Serir, A; Saugel, B Fluid therapy in adults having non-cardiac surgery: A narrative review
ANN INTENSIVE CARE. 2026; 16: 100006 Doi: 10.1016/j.aicoj.2025.100006
Web of Science FullText FullText_MUG

 

12.02.2026:

Sacher, F; Reichlin, T; Le, Bloa, M; Massoulie, G; Waintraub, X; Maury, P; Scherr, D; Tixier, R; Guy-Moyat, B; Duchateau, J; Meyer, C; Sermesant, M; Plant, A; Rousset, M; Gunawardene, MA; Bronnec, N; Gandjbakhch, E; Sacristan, B; Georget, A; Ditac, G; Azzouz, S; Haissaguerre, M; Willems, S; Derval, N; Tilz, RR; Hocini, M; Deneke, T; Pambrun, T; Rutten-van, Mölken, M; Pürerfellner, H; Englert, F; Sauer, E; Jais, P; Benard, A; Cochet, H Computed tomography-guided vs conventional catheter ablation for ventricular tachycardia: the InEurHeart trial.
Eur Heart J. 2026; Doi: 10.1093/eurheartj/ehag052
PubMed FullText FullText_MUG

 

11.02.2026:

Mendoza, JM; Weir, MR; Anker, SD; Filippatos, G; Rossing, P; Ahlers, C; Brinker, M; Fatoba, ST; Horvat-Broecker, A; Rohwedder, K; Fornoni, A, , FIDELIO-DKD, and, FIGARO-DKD, Investigators Finerenone in People with CKD, Type 2 Diabetes, and History of Nephrectomy.
Clin J Am Soc Nephrol. 2026; Doi: 10.2215/CJN.0000000932
PubMed FullText FullText_MUG

 

11.02.2026:

Pitt, JP; Müller, A; Nicholas, C; McCarthy, OM; Moser, O; Bain, SC; Sourij, H; Bracken, RM Comparison of pharmacodynamics and pharmacokinetics of ultra-rapid-acting insulin aspart and rapid-acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial.
Diabetes Obes Metab. 2026; Doi: 10.1111/dom.70487
PubMed FullText FullText_MUG

 

11.02.2026:

Tisch, M; Geisler, SM; Gabassi, E; Schlemmer, Q; Lechner, M; Ulz, JA; Suarez-Cubero, M; De, Gaetano, L; Spathopoulou, A; Striessnig, J; Ortner, NJ; Günther, K; Tuluc, P; Edenhofer, F Aberrant calcium signaling and neuronal activity in the L271H CACNA1D (Cav1.3) iPSC model of neurodevelopmental disease.
Mol Psychiatry. 2026; Doi: 10.1038/s41380-025-03429-8
PubMed FullText FullText_MUG

 

11.02.2026:

Török, F; Salamon, S; Ortner, NJ; Fernández-Quintero, ML; Matthes, J; Striessnig, J Inactivation induced by pathogenic Ca_v1.3 L-type Ca²⁺-channel variants enhances sensitivity for dihydropyridine Ca²⁺ channel blockers.
Br J Pharmacol. 2025; 182(1):181-197 Doi: 10.1111/bph.17357
PubMed FullText FullText_MUG

 

11.02.2026:

Nicholls, SJ; Pavo, I; Bhatt, DL; Buse, JB; Del, Prato, S; Kahn, SE; Lincoff, AM; McGuire, DK; Miller, D; Nauck, MA; Nishiyama, H; Nissen, SE; Sattar, N; Weerakkody, G; Wiese, RJ; Zinman, B; Zoungas, S; Basile, J; Davies, MJ; Giorgino, F; Kellerer, M; Ji, L; Varkonyi, T; Menon, V; Broder, JC; Herschtal, A; D'Alessio, D, , SURPASS-CVOT, Investigators Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes.
N Engl J Med. 2025; 393(24):2409-2420 Doi: 10.1056/NEJMoa2505928
PubMed FullText FullText_MUG

 

09.02.2026:

Skok, K; Scheipner, L; Mannweiler, S; Kashofer, K; Aigelsreiter, A; Milosevic, I; Leitsmann, C; Augustin, H; Rößmann-Tsybrovskyy, M; Ahyai, S; Liegl-Atzwanger, B; Mischinger, J Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomy.
BJU Int. 2026; Doi: 10.1111/bju.70157
PubMed FullText FullText_MUG

 

09.02.2026:

Peikert, A; Vacca, A; Norata, GD; Schiattarella, GG; Osto, E Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence.
Circ Heart Fail. 2026; e012674 Doi: 10.1161/CIRCHEARTFAILURE.125.012674
PubMed FullText FullText_MUG

 

09.02.2026:

Breschan, C; Graf, G; Arneitz, C; Stettner, H; Koestenberger, M; Likar, R Cannulation of the brachiocephalic vein in very low weight infants: analysis of a retrospective single-centre case series.
Br J Anaesth. 2026; Doi: 10.1016/j.bja.2025.12.044
PubMed FullText FullText_MUG

 

09.02.2026:

Sommer, P; Kronborg, MB; Sebag, F; Sohns, C; De, Potter, T; Bessière, F; Adragão, P; Pappone, C; Scherr, D; Duytschaever, M; Almorad, A Workflow and Sedation Choice With the PFA Variable-Loop Circular Catheter in Real-World AF Procedures: Insights From the Prospective Multi-Centre VARIPURE Clinical Study.
Europace. 2026; Doi: 10.1093/europace/euag025
PubMed FullText FullText_MUG

 

08.02.2026:

Förster, F; Horn, K; Pott, J; Delgado, GE; Kleber, ME; März, W; Moissl-Blanke, AP; Silbernagel, G; Waldenberger, M; Grallert, H; Peters, A; Gieger, C; Baber, R; Kirsten, H; Loeffler, M; Isermann, B; Thiery, J; Kovacs, P; Tönjes, A; Stumvoll, M; Gylling, H; Kähönen, M; Lehtimäki, T; Mishra, PP; Raitakari, O; Ceglarek, U; Scholz, M A genome-wide association meta-analysis of cholesterol synthesis intermediates identifies three associations for lanosterol.
EBioMedicine. 2026; 124: 106144 Doi: 10.1016/j.ebiom.2026.106144 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

07.02.2026:

Degezelle, MM; Chaami, C; Lewis, CTA; Zhang, C; Hessel, AL; Rainer, PP; Kirk, JA; Stokke, MK; Seaborne, RAE; Ochala, J Destabilization of cardiac myosin acetylation and sequestration with type 2 diabetes mellitus.
Cardiovasc Diabetol. 2026; Doi: 10.1186/s12933-025-03052-5
PubMed FullText FullText_MUG

 

07.02.2026:

Riedl, JM; Matsubara, H; McNeil, R; Patel, PS; Fece, de, la, Cruz, F; Gulhan, DC; Corcoran, RB Emerging landscape of KRAS inhibitors in cancer treatment.
Cancer Cell. 2026; Doi: 10.1016/j.ccell.2026.01.001
PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)

Med Uni Graz publications¹ were assigned quintiles according to the normalized² Clarivate’s Journal Impact Factor of the journal at the time of publication.

Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).

Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.

¹ This analysis considered only publications categorized as full papers/original articles.

² IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.